Nalaganje...
Live cumulative network meta-analysis: protocol for second-line treatments in advanced non-small-cell lung cancer with wild-type or unknown status for epidermal growth factor receptor
INTRODUCTION: Many second-line treatments for advanced non-small-cell lung cancer (NSCLC) have been assessed in randomised controlled trials, but which treatments work the best remains unclear. Novel treatments are being rapidly developed. We need a comprehensive up-to-date evidence synthesis of all...
Shranjeno v:
| izdano v: | BMJ Open |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4985872/ https://ncbi.nlm.nih.gov/pubmed/27489157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-011841 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|